WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report.
Furkejuvvon:
| Searvvušdahkkit: | , |
|---|---|
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Geneva :
World Health Organization,
2003.
|
| Ráidu: | Technical report series (World Health Organization) ;
908. |
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
MARC
| LEADER | 00000nam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | 0000068771 | ||
| 005 | 20171002053401.0 | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 030508s2003 sz s o000 0 eng d | ||
| 020 | |z 9241209089 | ||
| 035 | |a (CaPaEBR)ebr10040297 | ||
| 035 | |a (OCoLC)559412457 | ||
| 040 | |a CaPaEBR |c CaPaEBR | ||
| 050 | 1 | 4 | |a RA8.A247 |b W46 2003eb |
| 110 | 2 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations. |b Meeting |n (37th : |d 2001 : |c Geneva, Switzerland) | |
| 245 | 1 | 0 | |a WHO Expert Committee on Specifications for Pharmaceutical Preparations |h [electronic resource] : |b thirty-seventh report. |
| 260 | |a Geneva : |b World Health Organization, |c 2003. | ||
| 300 | |a viii, 145 p. | ||
| 490 | 1 | |a WHO technical report series, |x 0512-3054 ; |v 908 | |
| 505 | 0 | |a 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals. | |
| 533 | |a Electronic reproduction. |b Palo Alto, Calif. : |c ebrary, |d 2009. |n Available via World Wide Web. |n Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 | |a Drugs |x Standards |v Congresses. | |
| 650 | 0 | |a Drugs |x Specifications |v Congresses. | |
| 650 | 0 | |a Pharmaceutical industry |x Quality control |v Congresses. | |
| 655 | 7 | |a Electronic books. |2 local | |
| 710 | 2 | |a ebrary, Inc. | |
| 830 | 0 | |a Technical report series (World Health Organization) ; |v 908. | |
| 856 | 4 | 0 | |u http://site.ebrary.com/lib/daystar/Doc?id=10040297 |z An electronic book accessible through the World Wide Web; click to view |
| 908 | |a 170314 | ||
| 942 | 0 | 0 | |c EB |
| 999 | |c 57929 |d 57929 | ||